Speciality ingredient · Available under NDA

A proprietary Mulethi preparation — with the regulatory pathway already mapped.

Arvena Sciences has developed a proprietary preparation of Glycyrrhiza glabra (Mulethi / licorice root), available as a specialty active ingredient to supplement manufacturers under a signed NDA. Because it comes from a regulatory consultancy, not just an ingredient supplier, you get the compliance groundwork alongside the ingredient itself.

Enquire under NDA Learn more

At a glance

Botanical source: Glycyrrhiza glabra (Mulethi)
Form: Proprietary processed preparation
Access: Under signed NDA only
Suited to: Functional foods, nutraceuticals, herbal supplements
Regulatory support: Included in engagement scope

Available to supplement manufacturers · Under NDA

A proprietary Glycyrrhiza glabra active ingredient

Arvena Sciences has developed a proprietary active ingredient based on Glycyrrhiza glabra (Mulethi) — processed through a unique, fully proprietary preparation methodology developed and refined over 12 years of systematic observation.

Glycyrrhiza glabra has a well-documented traditional and scientific track record as an immunity-supporting botanical, recognised across Ayurvedic, Traditional Chinese, and European herbal medicine systems. The Arvena Sciences preparation takes this established botanical into a new dimension through its proprietary process.

For supplement manufacturers

The preparation is used at trace ratios of 1:200 to 1:500 as an active ingredient in finished supplement formulations. At these ratios it is exceptionally cost-effective, adds no perceptible taste or texture, and carries no known side effects even at higher concentrations. It is fully compatible with capsule, sachet, tablet, and liquid supplement formats.

The preparation methodology, process details, and ratio specifications are proprietary and not publicly disclosed. Details are shared verbally with serious manufacturers under a signed NDA. We do not make claims about outcomes — we invite manufacturers to experience results through a supervised sample trial.

For serious manufacturers only

Sample trial programme

We offer a paid sample programme for manufacturers who want to validate the ingredient in their own formulation before any licensing commitment:

Minimum trial: 500-unit supplement batch using Arvena Sciences' proprietary active ingredient
Ingredient supplied at the correct preparation ratio for your formulation
No outcome claims made by Arvena Sciences — the manufacturer observes and evaluates independently
Full NDA signed before any details are shared
Enquiries from serious manufacturers only — initial contact via the form below

Methodology, preparation process, and ratio specifications are proprietary. Per our NDA policy, details cannot be disclosed publicly.

Enquire under NDA

What comes with it

The ingredient itself

A standardized, quality-controlled Mulethi preparation, with full technical and safety documentation shared under NDA.

Regulatory pathway included

Because we're a regulatory consultancy first, we scope the FSSAI and target-export-market approval pathway for your specific formulation alongside the ingredient supply conversation — not as a separate, later engagement.

Formulation guidance

Dosage, combination, and stability guidance drawn from the same formulation research that produced the ingredient in the first place.